Senokot Syrup 150ml
Gentle effective constipation relief.
Product Features
- Contains natural Senna
- Works in 8-12 hours.
- Predictable overnight relief.
Pack Contents: 150 ML
Ingredients
Each 5 ml of Senokot Syrup contains calcium
sennosides equivalent to 7.5 mg per 5 ml total
sennosides (calculated as sennoside B).
Potassium sorbate E202
Methyl parahydroxybenzoate E218
Propyl parahydroxybenzoate E216
Maltitol liquid E965
Xanthan gum
Anti-foam (Medical C) emulsion
Prune flavour
Citric acid anhydrous
Purified water
Potassium sorbate E202
Methyl parahydroxybenzoate E218
Propyl parahydroxybenzoate E216
Maltitol liquid E965
Xanthan gum
Anti-foam (Medical C) emulsion
Prune flavour
Citric acid anhydrous
Purified water
Storage Instructions
Do not store above 25°C. Do not freeze
Usage Information
Senokot 7.5 mg/5 ml Syrup is for oral
administration.
Adults, including the elderly and children over 12: Two 5 ml spoonfuls.
Not to be given to children under 12 years except on medical advice. Where administration to children is necessary, the recommended dose is as follows.
Children over 6 years: One 5 ml spoonful.
Children aged 2 to 6 years: Half to one 5 ml spoonful in 24 hours.
Senokot should be taken as a single dose at bedtime by adults and in the morning by children.
New users should start with the lowest dose and increase it, if necessary, by one half of the initial dose each day. Once regularity has been regained the dosage should be gradually reduced and stopped.
Adults, including the elderly and children over 12: Two 5 ml spoonfuls.
Not to be given to children under 12 years except on medical advice. Where administration to children is necessary, the recommended dose is as follows.
Children over 6 years: One 5 ml spoonful.
Children aged 2 to 6 years: Half to one 5 ml spoonful in 24 hours.
Senokot should be taken as a single dose at bedtime by adults and in the morning by children.
New users should start with the lowest dose and increase it, if necessary, by one half of the initial dose each day. Once regularity has been regained the dosage should be gradually reduced and stopped.
Safety Information
Contraindications
Senokot 7.5 mg/5 ml Syrup should not be given when any undiagnosed acute or persistent abdominal symptoms are present.
Special warnings and precautions for use
Not to be given to children except on medical advice.
If there is no bowel movement after three days consult a doctor.
If laxatives are needed every day or abdominal pain persists consult a doctor.
Each 5 ml of syrup can provide up to 3.2 kcal and this should be taken into account when treating diabetics.
Patients with rare hereditary problems of fructose intolerance should not take this medicine.
The Physician should be satisfied that there is no underlying gastro intestinal pathology masking as constipation before recommending this product. Enquiry should be made about bowel habit, (particularly recent changes in bowel habit such as persistent diarrhoea or constipation), evacuation and bleeding per rectum.
Interaction with other medicinal products and other forms of interaction
None known.
Pregnancy and lactation
There is some evidence for the safety of senna derived products in human pregnancy which have been in use for many years without apparent illconsequence. If laxative treatment is required during pregnancy Senokot 7.5 mg/5 ml Syrup may be used.
Anthraquinones are excreted into breast milk, but clinical studies have shown that breast-fed infants of mothers taking senna derived products did not show any significant side-effects.
Effects on ability to drive and use machines
None known.
Undesirable effects
Temporary mild griping may occur during adjustment of the dosage. Hypersensitivity reactions associated with the esters of hydroxybenzoates (parabens) may occur.
Overdose
Where diarrhoea is severe conservative measures are usually sufficient; generous amounts of fluid, especially fruit drinks, should be given.
Senokot 7.5 mg/5 ml Syrup should not be given when any undiagnosed acute or persistent abdominal symptoms are present.
Special warnings and precautions for use
Not to be given to children except on medical advice.
If there is no bowel movement after three days consult a doctor.
If laxatives are needed every day or abdominal pain persists consult a doctor.
Each 5 ml of syrup can provide up to 3.2 kcal and this should be taken into account when treating diabetics.
Patients with rare hereditary problems of fructose intolerance should not take this medicine.
The Physician should be satisfied that there is no underlying gastro intestinal pathology masking as constipation before recommending this product. Enquiry should be made about bowel habit, (particularly recent changes in bowel habit such as persistent diarrhoea or constipation), evacuation and bleeding per rectum.
Interaction with other medicinal products and other forms of interaction
None known.
Pregnancy and lactation
There is some evidence for the safety of senna derived products in human pregnancy which have been in use for many years without apparent illconsequence. If laxative treatment is required during pregnancy Senokot 7.5 mg/5 ml Syrup may be used.
Anthraquinones are excreted into breast milk, but clinical studies have shown that breast-fed infants of mothers taking senna derived products did not show any significant side-effects.
Effects on ability to drive and use machines
None known.
Undesirable effects
Temporary mild griping may occur during adjustment of the dosage. Hypersensitivity reactions associated with the esters of hydroxybenzoates (parabens) may occur.
Overdose
Where diarrhoea is severe conservative measures are usually sufficient; generous amounts of fluid, especially fruit drinks, should be given.
Allergy Statement
Undesirable effects Temporary mild griping may
occur during adjustment of the dosage.
Hypersensitivity reactions associated with the
esters of hydroxybenzoates (parabens) may
occur.
Code:
GB_EN_05000158065758
Product Code: 05000158065758